Monday, November 18, 2024
- 10:30AM-12:30PM
-
Abstract Number: 1932
Effects of Clinical Decision Support on Transition Readiness Assessment in Pediatric Rheumatology
Health Services Research – ACR/ARP Poster III- 10:30AM-12:30PM
-
Abstract Number: 2353
Effects of Guselkumab on cDAPSA Disease Activity State and Its Association with Long-Term Radiographic Progression in a Cohort of Patients with Moderately-Highly Active Psoriatic Arthritis: Post Hoc Analyses of Phase 3 Randomized Controlled Studies
SpA Including PsA – Treatment Poster III- 10:30AM-12:30PM
-
Abstract Number: 1999
Effects of JAK Inhibitors on Subsets of the Innate Immune System
Immunological Complications of Medical Therapy Poster- 10:30AM-12:30PM
-
Abstract Number: 2084
Efficacy and Safety of a Step-down Regimen of Low Dosage of Glucocorticoids Combined with Early Administration of Synthetic or Biologic Immunosuppressants in Anti-synthetase Syndrome: A Pilot Study
Muscle Biology, Myositis & Myopathies – Basic & Clinical Science Poster III- 10:30AM-12:30PM
-
Abstract Number: 2483
Efficacy and Safety of Avacopan over 12 Months in Japanese Patients with MPA/GPA: A Single-center Study
Vasculitis – ANCA-Associated Poster III- 10:30AM-12:30PM
-
Abstract Number: 1980
Efficacy and Safety of Methotrexate in Immune Checkpoint Inhibitor-induced Arthritis: A Retrospective Longitudinal Monocentric Study
Immunological Complications of Medical Therapy Poster- 10:30AM-12:30PM
-
Abstract Number: 2274
Efficacy and Safety of the Biased Melanocortin Receptor Agonist AP1189/resomelagon in Combination with Methotrexate in DMARD-naïve Rheumatoid Arthritis Patients: The EXPAND Trial
RA – Treatment Poster III- 10:30AM-12:30PM
-
Abstract Number: 2355
Efficacy of Risankizumab Across Distinct PsA Phenotypes Identified with Machine Learning Analytics Using Data from Biologic DMARD-Naive Patients in Two Phase 3 Clinical Trials
SpA Including PsA – Treatment Poster III- 10:30AM-12:30PM
-
Abstract Number: 2467
Elderly Systemic Sclerosis. Clinical Presentation and Outcome
Systemic Sclerosis & Related Disorders – Clinical Poster III- 10:30AM-12:30PM
-
Abstract Number: 1942
Electronic Health Literacy and Its Association with Disease Activity in RMD Patients – a Cross Sectional Study
Health Services Research – ACR/ARP Poster III- 10:30AM-12:30PM
-
Abstract Number: 2013
Elevated Serum Allantoin and Allantoin/uric Acid Ratio as Indicators of Oxidative Stress in Severe Gout and Cardiovascular Comorbidities
Metabolic & Crystal Arthropathies – Basic & Clinical Science Poster III- 10:30AM-12:30PM
-
Abstract Number: 1813
Elucidating the Molecular Correlates of Treatment Response in Lupus Nephritis via Imaging Mass Cytometry Proteomics and Machine Learning
SLE – Etiology & Pathogenesis Poster- 10:30AM-12:30PM
-
Abstract Number: 1890
Emergency Department Visits for Ambulatory Care Sensitive Conditions by Persons with Rheumatoid Arthritis: A Population-Based Study
Epidemiology & Public Health Poster III- 10:30AM-12:30PM
-
Abstract Number: 1767
Endothelial Cell-Driven JAG/NOTCH Signaling in Localized Scleroderma Patients